Ling‐Ming Tseng
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 79
- HER2/EGFR in Cancer Research 31
- Cancer Cells and Metastasis 12
-
- Mitochondrial Function and Pathology 11
- RNA modifications and cancer 11
- Co-authors
- Hsin‐Chen Lee (19 shared papers)Luca Gianni (8 shared papers)Pinuccia Valagussa (8 shared papers)Tadeusz Pieńkowski (8 shared papers)Giulia Bianchi (7 shared papers)Young‐Hyuck Im (7 shared papers)Seock‐Ah Im (9 shared papers)Aňa Lluch (5 shared papers)
- Journals
- Cancer Research (15 papers)Journal of Clinical Oncology (11 papers)Breast Cancer Research and Treatment (7 papers)Scientific Reports (6 papers)PLoS ONE (6 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Ling‐Ming Tseng
224 papers receiving 9.1k citations
Ling‐Ming Tseng's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 2.5k
- Oncology 4.0k
- Molecular Biology 3.3k
- Radiology, Nuclear Medicine and Imaging 992
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Ling‐Ming Tseng
This map shows the geographic impact of Ling‐Ming Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Ming Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Ming Tseng more than expected).
Fields of papers citing papers by Ling‐Ming Tseng
This network shows the impact of papers produced by Ling‐Ming Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Ming Tseng. The network helps show where Ling‐Ming Tseng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling‐Ming Tseng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Hit paper breakdown → | 2011 | 1629 |
| 2 | 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial Hit paper breakdown → | 2016 | 582 |
| 3 | 2011 | 439 | |
| 4 | 2009 | 409 | |
| 5 | 2016 | 250 | |
| 6 | 2017 | 237 | |
| 7 | 2006 | 221 | |
| 8 | 2007 | 165 | |
| 9 | 2016 | 140 | |
| 10 | 2012 | 131 | |
| 11 | 2012 | 126 | |
| 12 | 2011 | 124 | |
| 13 | 2010 | 118 | |
| 14 | 2010 | 116 | |
| 15 | 2011 | 115 | |
| 16 | 2012 | 109 | |
| 17 | 2010 | 105 | |
| 18 | 2023 | 105 | |
| 19 | 2011 | 98 | |
| 20 | 2015 | 97 |
About Ling‐Ming Tseng
Ling‐Ming Tseng is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 233 papers that have together received 9.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (31 papers), Breast Cancer Treatment Studies (24 papers), Advanced Breast Cancer Therapies (24 papers), Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (12 papers), Cancer, Hypoxia, and Metabolism (12 papers), Mitochondrial Function and Pathology (11 papers) and RNA modifications and cancer (11 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (4.0k citations), Molecular Biology (3.3k citations), Radiology, Nuclear Medicine and Imaging (992 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Ling‐Ming Tseng has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Hsin‐Chen Lee, Luca Gianni, Pinuccia Valagussa, Tadeusz Pieńkowski, Giulia Bianchi, Young‐Hyuck Im, Seock‐Ah Im, Aňa Lluch, Brigitte Poirier and Juan de la Haba-Rodríguez. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Scientific Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.